Lewy Body Dementia (LBD)
11
5
5
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (11)
Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients (DetectAI)
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypical Parkinsonisms and Neurocognitive Disorders Due to Lewy Body Disease
18F-mFBG Cardiac Uptake With Lewy Body Dementia
Social-cognitive Functioning: Validation of a New Neuropsychological Test
Transcranial Alternating Current Stimulation in Lewy Body Dementia
Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia Patients
Investigating Genetic Status in Patients Presenting to Clinic
The Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias
Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System
PST for Care Partners of Adults With Alzheimer's and Alzheimer'S-related Dementia